Opthea Aktie - OPT

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

3,18

Gebot

2,67

Fragen

3,88

Volumen

86.405

3,03 Tagesbereich 3,4503

0,00 52-Wochen-Bereich 0,00

Marktkapitalisierung

489,36M

Handelsende

3,07

Handelsbeginn

3,22

Letzte Trade

3.18

Letzter Handelszeitpunkt

Finanzvolumen

US$ 281.150

VWAP

3,2539

Durchschnittliches Volumen (3 Mio.)

Ausgegebene Aktien

153.886.827

Dividendenrendite

Kurs-Gewinn-Verhältnis

-0,42

Gewinn pro Aktie (EPS)

-1,43

Erlöse

262k

Nettogewinn

-220,24M

Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases.

Sektor

Health & Allied Services,nec

Branche

Health & Allied Services,nec

Website

www.opthea.com

Hauptsitz

Melbourne, Victoria, Aus

Gegründet

1984

Opthea Ltd is listed in the Health & Allied Services sector of the NASDAQ with ticker OPT. The last closing price for Opthea was US$3,07. Over the last year, Opthea shares have traded in a share price range of US$ 0,00 to US$ 0,00.

Opthea currently has 153.886.827 shares in issue. The market capitalisation of Opthea is US$472,43 million. Opthea has a price to earnings ratio (PE ratio) of -0.42.

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

OPT - Frequently Asked Questions (FAQ)

What is the current Opthea share price?

The current share price of Opthea is US$ 3,18

How many Opthea shares are in issue?

Opthea has 153.886.827 shares in issue

What is the market cap of Opthea?

The market capitalisation of Opthea is USD 472,43M

What is the 1 year trading range for Opthea share price?

Opthea has traded in the range of US$ 0,00 to US$ 0,00 during the past year

What is the PE ratio of Opthea?

The price to earnings ratio of Opthea is -0,42

What is the cash to sales ratio of Opthea?

The cash to sales ratio of Opthea is 352,94

What is the reporting currency for Opthea?

Opthea reports financial results in USD

What is the latest annual turnover for Opthea?

The latest annual turnover of Opthea is USD 262k

What is the latest annual profit for Opthea?

The latest annual profit of Opthea is USD -220,24M

What is the registered address of Opthea?

The registered address for Opthea is LEVEL 4, 650 CHAPEL STREET, SOUTH YARRA, MELBOURNE, VICTORIA, 3141

What is the Opthea website address?

The website address for Opthea is www.opthea.com

Which industry sector does Opthea operate in?

Opthea operates in the HEALTH & ALLIED SERVICES,NEC sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
RDUSRadius Recycling Inc	US$ 27,902 (104,26%)	8,53M
BONBon Natural Life Ltd	US$ 1,40 (90,29%)	84M
SUNESUNation Energy Inc	US$ 0,5213 (62,96%)	513,96M
WHLRLWheeler Real Estate Investment Trust Inc	US$ 255,00 (39,80%)	222
AAOIApplied Optoelectronics Inc	US$ 22,105 (39,29%)	17,01M
GLSTUGlobal Star Acquisition Inc	US$ 2,00 (-69,23%)	421
CURRCurrenc Group Inc	US$ 2,03 (-41,33%)	1,42M
ADTXAditxt Inc	US$ 0,0201 (-39,82%)	240,2M
HEPAHepion Pharmaceuticals Inc	US$ 0,0228 (-39,68%)	161,52M
WKSPWorksport Ltd	US$ 0,36205 (-35,45%)	4,96M
SUNESUNation Energy Inc	US$ 0,5213 (62,96%)	513,96M
NVDANVIDIA Corporation	US$ 121,67 (5,27%)	277,56M
ADTXAditxt Inc	US$ 0,0201 (-39,82%)	240,2M
HEPAHepion Pharmaceuticals Inc	US$ 0,0228 (-39,68%)	161,52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 9,225 (7,64%)	160,21M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Opthea Ltd (OPT)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Über Opthea Ltd

OPT Neueste Nachrichten

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Optima Health Secures First License with the NHS for its Digital Assessment Routing Tool ‘DART’

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Optima Health Secures First License with the NHS for its Digital Assessment Routing Tool ‘DART’

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

OPT - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Opthea Ltd (OPT) Börsenkurse

Opthea Ltd (OPT)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Über Opthea Ltd

OPT Neueste Nachrichten

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Optima Health Secures First License with the NHS for its Digital Assessment Routing Tool ‘DART’

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Optima Health Secures First License with the NHS for its Digital Assessment Routing Tool ‘DART’

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

OPT - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR